
Ten clinical-grade compounds. Active forms only. Three capsules, once a day.
Plant-based shell. No fillers, no dyes, no shortcuts.
The complete daily panel — every active, every salt, every dose, every role. Printed here, on the bottle, and on every certificate of analysis. Hover any tile or row for context.
Hashimoto's isn't one failure — it's a cascade. Immune dysregulation triggers oxidative stress, which blunts hormone conversion, which collapses methylation. CoreAxis intervenes at every link.
TPO antibodies fall. Th1/Th17 polarization dampens. The autoimmune driver is reined in.
Reactive oxygen species generated by chronic thyroid inflammation are neutralized at the source.
Type-1 and type-2 deiodinases come back online. Active T3 — the form your cells actually use — gets produced.
Methylation cycle restored. The persistent fatigue and brain fog that lab numbers miss begin to lift.
I was diagnosed with Hashimoto's at 28. Levothyroxine brought my TSH back into range and most of my symptoms stayed. The fatigue, the brain fog, the cold — none of the twelve multivitamins I tried moved the needle.
So I spent two years reading the trials, working with an endocrinologist and a clinical nutritionist, and rebuilding what a thyroid protocol should actually look like. Core Axis is what I now take every morning.
Most members feel a measurable shift in energy and mental clarity within three to six weeks. The protocol is designed for continuous use; subscription is the default and is recommended.
“The transparency is what convinced me. Every dose stated, every salt named. As a clinician, I want to know exactly what I am recommending.”
“I had been on three separate supplements to cover the same actives. CoreAxis consolidates them at clinical doses. My TPO antibodies dropped meaningfully over six months.”
“A formulation I can read in thirty seconds and defend in front of a peer-review committee. That is rare in this category.”
A multivitamin is built for population-level deficiency prevention at minimum effective doses. CoreAxis is built for one autoimmune condition at therapeutic doses, using only forms with established bioavailability. The two products solve different problems.